P. Zerbinati

1.0k total citations
36 papers, 714 citations indexed

About

P. Zerbinati is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, P. Zerbinati has authored 36 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 16 papers in Genetics and 8 papers in Internal Medicine. Recurrent topics in P. Zerbinati's work include Blood Coagulation and Thrombosis Mechanisms (13 papers), Hemophilia Treatment and Research (10 papers) and Platelet Disorders and Treatments (9 papers). P. Zerbinati is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (13 papers), Hemophilia Treatment and Research (10 papers) and Platelet Disorders and Treatments (9 papers). P. Zerbinati collaborates with scholars based in Italy, United States and Taiwan. P. Zerbinati's co-authors include Antonio Girolami, Paolo Simioni, Daniela Tormene, Sabrina Gavasso, A Girolami, Maria Luigia Randi, Elena Pontara, Alessandra Casonato, Carlo Riccardo Rossi and Claudia Maria Radu and has published in prestigious journals such as Blood, Journal of Hepatology and British Journal of Haematology.

In The Last Decade

P. Zerbinati

34 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Zerbinati Italy 15 473 204 151 134 131 36 714
Christine Biron‐Andréani France 17 586 1.2× 257 1.3× 102 0.7× 130 1.0× 118 0.9× 54 811
J Wilde United Kingdom 18 638 1.3× 92 0.5× 237 1.6× 50 0.4× 205 1.6× 34 1.1k
A Chitolie United Kingdom 13 245 0.5× 123 0.6× 50 0.3× 108 0.8× 138 1.1× 29 548
K. Auberger Germany 13 475 1.0× 248 1.2× 46 0.3× 143 1.1× 123 0.9× 22 574
Philip Kuriakose United States 13 245 0.5× 98 0.5× 129 0.9× 66 0.5× 114 0.9× 91 546
Francesco Dragoni Italy 15 210 0.4× 48 0.2× 136 0.9× 37 0.3× 99 0.8× 28 589
Jyh‐Pyng Gau Taiwan 14 277 0.6× 85 0.4× 95 0.6× 59 0.4× 76 0.6× 74 659
Thita Chiasakul Thailand 14 192 0.4× 203 1.0× 58 0.4× 141 1.1× 95 0.7× 38 559
G Tchernia France 11 324 0.7× 83 0.4× 143 0.9× 49 0.4× 79 0.6× 43 547
Yves Gruel France 14 202 0.4× 294 1.4× 26 0.2× 285 2.1× 261 2.0× 33 714

Countries citing papers authored by P. Zerbinati

Since Specialization
Citations

This map shows the geographic impact of P. Zerbinati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Zerbinati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Zerbinati more than expected).

Fields of papers citing papers by P. Zerbinati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Zerbinati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Zerbinati. The network helps show where P. Zerbinati may publish in the future.

Co-authorship network of co-authors of P. Zerbinati

This figure shows the co-authorship network connecting the top 25 collaborators of P. Zerbinati. A scholar is included among the top collaborators of P. Zerbinati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Zerbinati. P. Zerbinati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campello, Elena, Chiara Simion, Cristiana Bulato, et al.. (2021). Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study. Thrombosis Research. 205. 24–28. 18 indexed citations
2.
Campello, Elena, Luca Spiezia, Claudia Maria Radu, et al.. (2014). Circulating microparticles in carriers of prothrombin G20210A mutation. Thrombosis and Haemostasis. 112(9). 432–437. 12 indexed citations
3.
Radu, Claudia Maria, Sabrina Gavasso, P. Zerbinati, et al.. (2013). 235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS. Journal of Hepatology. 58. S101–S101. 1 indexed citations
4.
Campello, Elena, Luca Spiezia, Claudia Maria Radu, et al.. (2012). Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. Thrombosis and Haemostasis. 108(10). 633–639. 28 indexed citations
5.
Senzolo, Marco, K. Rodriguez-Castro, Valeria Rossetto, et al.. (2012). Increased anticoagulant response to low‐molecular‐weight heparin in plasma from patients with advanced cirrhosis. Journal of Thrombosis and Haemostasis. 10(9). 1823–1829. 69 indexed citations
6.
Cozzi, Emanuele, Paolo Simioni, M Boldrin, et al.. (2004). Alterations in the Coagulation Profile in Renal Pig-to-Monkey Xenotransplantation. American Journal of Transplantation. 4(3). 335–345. 22 indexed citations
7.
Vianello, Fabrizio, Donata Belvini, Federico Dal Bello, et al.. (2001). Mild bleeding diathesis in a boy with combined severe haemophilia B (C10400→T) and heterozygous factor V Leiden. Haemophilia. 7(5). 511–514. 24 indexed citations
8.
Tormene, Daniela, et al.. (2001). Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.. PubMed. 86(12). 1305–9. 41 indexed citations
9.
Zanon, Ezio, P. Zerbinati, Bruno Girolami, Antonella Bertomoro, & A Girolami. (1999). Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates. Blood Coagulation & Fibrinolysis. 10(3). 117–120. 11 indexed citations
10.
Rossi, Carlo Riccardo, et al.. (1998). Acute coronary disease in essential thrombocythemia and polycythemia vera. Journal of Internal Medicine. 243(7). 49–53. 75 indexed citations
11.
Casonato, Alessandra, et al.. (1998). The Evaluation of Factor VIII Binding Activity of von Willebrand Factor by Means of an ELISA Method:Significance and Practical Implications. American Journal of Clinical Pathology. 109(3). 347–352. 36 indexed citations
12.
Rossi, Carlo Riccardo, Maria Luigia Randi, P. Zerbinati, Giuseppe Cella, & Antonio Girolami. (1997). Thrombocytosis in Malignancy: A Paraneoplastic Syndrome?. Hematology. 2(3). 229–233. 1 indexed citations
13.
Paolini, Rossella, Emma D’Andrea, Alessandro Poletti, et al.. (1996). B Non-Hodgkin's Lymphoma in a Haemophilia Patient with Idiopathic CD4+ T-lymphocytopenia. Leukemia & lymphoma. 21(1-2). 177–180. 9 indexed citations
14.
Dazzi, Francesco, Fabrizio Vianello, Paolo Radossi, et al.. (1996). High incidence of anti‐FVIII antibodies against non‐coagulant epitopes in haemophilia A patients: a possible role for the half‐life of transfused FVIII. British Journal of Haematology. 93(3). 688–693. 57 indexed citations
15.
Zerbinati, P., et al.. (1996). Essential thrombocythemia following polycythemia vera: an unusual sequence.. PubMed. 27(5-6). 363–8.
16.
Sartori, Maria, et al.. (1995). Heterozygous factor VII deficiency and severe hemophilia A in the same kindred. Blood Coagulation & Fibrinolysis. 6(7). 676–679. 1 indexed citations
17.
Casonato, Alessandra, Elena Pontara, Antonella Bertomoro, et al.. (1994). Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrandʼs disease. Blood Coagulation & Fibrinolysis. 5(6). 959–964. 12 indexed citations
18.
Casonato, Alessandra, Francesco Pietrogrande, Elena Pontara, et al.. (1994). Acquired Factor VIII: C Inhibitor in a Patient with Sjögren’s Syndrome: Successful Treatment with Steroid and Immunosuppressive Therapy. Acta Haematologica. 91(2). 73–76. 17 indexed citations
19.
Sartori, Michelangelo, et al.. (1994). Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.. PubMed. 26(1). 17–27.
20.
Zerbinati, P., et al.. (1993). The importance of serial immunoglobulin evaluations in HIV-seropositive haemophiliacs.. PubMed. 25(4). 271–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Biron‐Andréani Breakdown of academic impact, for papers by J Wilde Breakdown of academic impact, for papers by A Chitolie Breakdown of academic impact, for papers by K. Auberger Breakdown of academic impact, for papers by Philip Kuriakose Breakdown of academic impact, for papers by Francesco Dragoni Breakdown of academic impact, for papers by Jyh‐Pyng Gau Breakdown of academic impact, for papers by Thita Chiasakul Breakdown of academic impact, for papers by G Tchernia Breakdown of academic impact, for papers by Yves Gruel
Rankless by CCL
2026